# IGHMBP2

## Overview
The IGHMBP2 gene encodes the immunoglobulin mu DNA binding protein 2, a multifunctional protein that belongs to the superfamily 1 (SF1) of DNA/RNA helicases. This protein is characterized by its ability to unwind both DNA and RNA duplexes, facilitated by its ATP-dependent helicase activity. Structurally, IGHMBP2 contains a DNA/RNA helicase domain, an R3H domain, and a zinc-finger domain, which collectively contribute to its nucleic acid binding and processing capabilities (Lim2012The; Guenther2009IGHMBP2). Functionally, IGHMBP2 is involved in critical cellular processes such as mRNA translation, transcription, and immunoglobulin class switching, with a significant role in the maturation of neuronal mRNAs (Park2023IGHMBP2; Pedurupillay2016Clinical). Clinically, mutations in the IGHMBP2 gene are linked to neuromuscular disorders, including Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1) and Charcot-Marie-Tooth disease type 2S (CMT2S), highlighting its importance in human health and disease (Tran2024A; Tian2023Exploring).

## Structure
The IGHMBP2 protein is a multidomain protein that includes a DNA/RNA helicase domain, an R3H domain, and a zinc-finger domain. The helicase domain is structurally similar to the Upf1 protein and consists of two RecA-like domains (1A and 2A) and two subdomains (1B and 1C) inserted into domain 1A (Lim2012The). Domains 1A and 2A have an alpha-beta fold with a central seven-stranded parallel beta-sheet surrounded by alpha helices, characteristic of SF1 and SF2 helicases (Lim2012The). Domain 1B is composed of a short alpha-helix and a beta-barrel, connected to domain 1A by two alpha-helices known as the 'stalk'. Domain 1C is inserted between the Walker A and Walker B motifs and forms four helices above domain 1A (Lim2012The).

The R3H domain, located downstream of the helicase core, enhances RNA binding and ATPase activities. It is characterized by a conserved arginine and histidine separated by three residues, forming a three-stranded anti-parallel beta-sheet and two alpha-helices with a positively charged surface (Lim2012The). The zinc-finger domain is also present, contributing to the protein's nucleic acid binding capabilities (Guenther2009IGHMBP2). The protein is an ATP-dependent 5' to 3' DNA/RNA helicase, capable of unwinding both DNA and RNA duplexes (Lim2012The).

## Function
IGHMBP2 is a superfamily 1 DNA/RNA helicase that plays a critical role in the regulation of mRNA translation in healthy human cells. It is predominantly located in the cytoplasm, where it co-localizes with translation initiation factor eIF4G2 and rRNA, indicating that its primary physiological substrate is RNA (Park2023IGHMBP2). IGHMBP2 interacts with the translational machinery, as evidenced by its co-precipitation and co-sedimentation with ribosomal proteins and subunits, and it associates with macromolecules involved in translational regulation, such as elongation factors and tRNA-Tyr (Park2023IGHMBP2).

The protein is involved in several critical cellular processes, including transcription, pre-mRNA processing, translation, and immunoglobulin class switching (Pedurupillay2016Clinical). It plays a role in the maturation of mRNAs in neurons, which is essential for normal neuronal function (Pedurupillay2016Clinical). IGHMBP2's helicase activity is crucial for its function, as it involves ATP binding and nucleic acid interactions, which are typical functions of helicases (Lim2012The). The protein's ability to unwind both DNA and RNA duplexes is attributed to its lack of specific recognition of the 2'-OH group of the ribose sugar, making it unspecific to DNA or RNA (Lim2012The).

## Clinical Significance
Mutations in the IGHMBP2 gene are associated with two primary neuromuscular disorders: Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1) and Charcot-Marie-Tooth disease type 2S (CMT2S). SMARD1 is characterized by early-onset respiratory distress, diaphragmatic paralysis, and distal muscular weakness, often leading to death within the first few years of life. This condition is typically caused by truncating mutations in the IGHMBP2 gene, particularly in the helicase domain, which are crucial for the disease's pathogenesis (Tran2024A; Tian2023Exploring).

CMT2S, on the other hand, is a milder form of hereditary motor sensory neuropathy, presenting with distal muscle weakness and sensory loss without respiratory issues. It is associated with mutations in the 5′ region and the last exon of the IGHMBP2 gene, including nonsense, frameshift, and missense mutations (Tran2024A; Tian2023Exploring). The clinical presentation of these conditions can overlap, and the same genetic variants can lead to different diagnoses, suggesting a phenotypic spectrum rather than distinct diseases (Tran2024A).

The variability in clinical outcomes may be due to differences in residual enzymatic activity of IGHMBP2, post-translational degradation, or interactions with modifier genes and other proteins involved in RNA processing (Tran2024A).

## Interactions
IGHMBP2 is a ribosome-associated helicase that interacts with various proteins and nucleic acids, playing a significant role in the translational machinery. It forms complexes with ribosomal subunits and components of the translational apparatus, including 5S, 18S, and 28S rRNAs (Guenther2009IGHMBP2). IGHMBP2 associates with both the small (40S) and large (60S) ribosomal subunits and is involved in the formation of 80S ribosomes, indicating its role in translation initiation (Guenther2009IGHMBP2).

The protein also interacts with ABT1, a protein that enhances IGHMBP2's ATPase and helicase activities. This interaction is characterized by a high binding affinity, with a dissociation constant of approximately 52 nM, and is crucial for IGHMBP2's function in RNA processing (Vadla2023ABT1). The presence of ABT1 stabilizes IGHMBP2's binding to U3 snoRNA, suggesting a role in pre-rRNA processing (Vadla2023ABT1).

IGHMBP2 also interacts with other proteins such as helicases Reptin and Pontin, and TFIIIC220, which are essential for tRNA transcription and ribosome biogenesis (de2009Biochemical). These interactions highlight IGHMBP2's involvement in the regulation of translation and RNA metabolism.


## References


[1. (Guenther2009IGHMBP2) Ulf-Peter Guenther, Lusy Handoko, Bernhard Laggerbauer, Sibylle Jablonka, Ashwin Chari, Mona Alzheimer, Jürgen Ohmer, Oliver Plöttner, Niels Gehring, Albert Sickmann, Katja von Au, Markus Schuelke, and Utz Fischer. Ighmbp2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal sma type 1 (dsma1). Human Molecular Genetics, 18(7):1288–1300, January 2009. URL: http://dx.doi.org/10.1093/hmg/ddp028, doi:10.1093/hmg/ddp028. This article has 83 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp028)

[2. (Tran2024A) Van Khanh Tran, My Ha Cao, Thi Thanh Hai Nguyen, Phuong Thi Le, Hai Anh Tran, Dung Chi Vu, Ha Thu Nguyen, Mai Thi Phương Nguyen, The-Hung Bui, Thanh Binh Nguyen, Thanh Van Ta, and Thinh Huy Tran. A novel ighmbp2 variant and clinical diversity in vietnamese smard1 and cmt2s patients. Frontiers in Pediatrics, February 2024. URL: http://dx.doi.org/10.3389/fped.2024.1165492, doi:10.3389/fped.2024.1165492. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2024.1165492)

[3. (Pedurupillay2016Clinical) Christeen Ramane J. Pedurupillay, Silja S. Amundsen, Tuva Barøy, Magnhild Rasmussen, Anne Blomhoff, Barbro Fossøy Stadheim, Kristin Ørstavik, Asbjørn Holmgren, Tahir Iqbal, Eirik Frengen, Doriana Misceo, and Petter Strømme. Clinical and molecular characteristics in three families with biallelic mutations in ighmbp2. Neuromuscular Disorders, 26(9):570–575, September 2016. URL: http://dx.doi.org/10.1016/j.nmd.2016.06.457, doi:10.1016/j.nmd.2016.06.457. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.nmd.2016.06.457)

[4. (de2009Biochemical) Mariàngels de Planell-Saguer, David G. Schroeder, Maria Celina Rodicio, Gregory A. Cox, and Zissimos Mourelatos. Biochemical and genetic evidence for a role of ighmbp2 in the translational machinery. Human Molecular Genetics, 18(12):2115–2126, March 2009. URL: http://dx.doi.org/10.1093/hmg/ddp134, doi:10.1093/hmg/ddp134. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp134)

5. (Park2023IGHMBP2) IGHMBP2 deletion suppresses translation and activates the integrated stress response. This article has 1 citations.

[6. (Vadla2023ABT1) Gangadhar P. Vadla, Sara M. Ricardez Hernandez, Jiude Mao, Mona O. Garro-Kacher, Zachary C. Lorson, Ronin P. Rice, Sarah A. Hansen, Christian L. Lorson, Kamal Singh, and Monique A. Lorson. Abt1 modifies smard1 pathology via interactions with ighmbp2 and stimulation of atpase and helicase activity. JCI Insight, January 2023. URL: http://dx.doi.org/10.1172/jci.insight.164608, doi:10.1172/jci.insight.164608. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1172/jci.insight.164608)

[7. (Lim2012The) Siew Choo Lim, Matthew W. Bowler, Ting Feng Lai, and Haiwei Song. The ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in dmsa1. Nucleic Acids Research, 40(21):11009–11022, September 2012. URL: http://dx.doi.org/10.1093/nar/gks792, doi:10.1093/nar/gks792. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gks792)

[8. (Tian2023Exploring) Yuan Tian, Jinfang Xing, Ying Shi, and Enwu Yuan. Exploring the relationship between ighmbp2 gene mutations and spinal muscular atrophy with respiratory distress type 1 and charcot-marie-tooth disease type 2s: a systematic review. Frontiers in Neuroscience, November 2023. URL: http://dx.doi.org/10.3389/fnins.2023.1252075, doi:10.3389/fnins.2023.1252075. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2023.1252075)